#52 How is Anima Biotech changing the game on identifying the mechanism of action?

BioTech IQ

English - July 01, 2022 21:00 - 1 hour - 42.5 MB - ★★★★★ - 9 ratings
Life Sciences Science Business Investing Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: #51 Cell Cycle Therapy: Understanding The Cell Cycle Biology To Treat Cancer With Spiro Rombotis

Next Episode: #52 Harnessing the Innate Immune System By Developing Three Types of iPSC-Derived Natural Killer Cells With Daniel Teper

On this episode of BioTech IQ Ammon talks with Co-Founder and CEO of Anima Biotech, Yochi Slonim. Yochi is a serial entrepreneur with experience building multiple successful companies before starting Co-Founding Anima. Anima Biotech is developing mRNA Lighting, a novel platform for the discovery of selective small molecule mRNA drugs and their mechanisms of action. Automated high scale phenotypic screening combining live biology with AI mRNA image analysis for the discovery of small molecule mRNA drugs and their mechanisms of action.

https://www.animabiotech.com/

Catch the latest on BioTech IQ
https://thebiotechiqpodcast.com/

Support the show

Check me out on LinkedIn https://www.linkedin.com/in/ammonr/